Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Seminars in Cardiovascular Medicine

The Journal of Lithuanian Heart Association

1 Issue per year

Open Access
Online
ISSN
1822-7767
See all formats and pricing
More options …

Lithuanian High Cardiovascular Risk (LitHiR) primary prevention programme - rationale and design

Aleksandras Laucevičius
  • Vilnius University Hospital Santariškių Klinikos, Vilnius, Lithuania
  • Informeda Enterprise, Vilnius, Lithuania
  • Department of Cardiovascular, Medicine Vilnius University, Vilnius, Lithuania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Vytautas Kasiulevičius / Dalius Jatužis
  • Vilnius University Hospital Santariškių Klinikos, Vilnius, Lithuania
  • Department of Cardiovascular, Medicine Vilnius University, Vilnius, Lithuania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Žaneta Petrulionienė
  • Vilnius University Hospital Santariškių Klinikos, Vilnius, Lithuania
  • Department of Cardiovascular, Medicine Vilnius University, Vilnius, Lithuania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ligita Ryliškytė
  • Vilnius University Hospital Santariškių Klinikos, Vilnius, Lithuania
  • Department of Cardiovascular, Medicine Vilnius University, Vilnius, Lithuania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Egidija Rinkūnienė / Jolita Badarienė / Alma ypienė / Olivija Gustienė / Rimvydas Šlapikas
Published Online: 2012-07-20 | DOI: https://doi.org/10.2478/v10287-012-0003-3

Lithuanian High Cardiovascular Risk (LitHiR) primary prevention programme - rationale and design

Objectives: According to the latest WHO data, coronary heart disease deaths in Lithuania reached 38.3% of total deaths. Based on the unfavourable situation with cardiovascular morbidity and mortality in Lithuania the Lithuanian High Cardiovascular Risk (LitHiR) programme aimed at estimation and aggressive managing of cardiovascular risk factors. This paper describes the Lithuanian High Cardiovascular Risk programme protocol.

Design and methods: In 2006 the Lithuanian High Cardiovascular Risk programme was started. LitHiR programme recruited men - at the age of 40-54 years and women - 50-64 years without overt cardiovascular disease. The two-level approach - primary health care institutions (PHCI) and specialized cardiovascular prevention units (CVPU) - was applied. The subjects selected were tested for cardiovascular risk and those with high cardiovascular risk were sent to secondary (CVPU) level, for other the plan of preventive measures of risk factor reduction was created. In years 2006-2010 overall 266,391 persons (36.9% from all target population) were examined. Among them 164,657 subjects (61.8%) were tested for the first time, 68,832 (25.8%) were tested repeatedly one time, 32,848 subjects (12.3%) were tested repeatedly for two and more times.

Conclusions: The programme aimed at estimation and managing of cardiovascular risk factors striving to reduce acute cardiovascular event related morbidity and mortality, to slow down the progression of sub-clinical atherosclerosis into overt cardiovascular disease, to increase the number of newly identified cases of diabetes, metabolic syndrome and latent course of atherosclerosis related diseases, to decrease hospitalizations for treatment of arterial hypertension and coronary heart disease.

Keywords: ardiovascular risk; primary prevention; dyslipidemia

  • De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J et al. European guidelines on cardiovascular disease prevention in clinical practice. Executive Summary. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur Heart J 2003; 24:1601-1610.Google Scholar

  • Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-952.Google Scholar

  • Puska P. The North Karelia Project: 30 years successfully preventing chronic diseases. Diabetes Voice 2008; 53:26-29.Google Scholar

  • Fras Z, Zakotnik JM, Govc Erzen J, Leskosek B. Comprehensive nationwide programme on cardiovascular prevention in Slovenia-first 3-years experience [abstract]. In: Abstract book, 17th Annual Meeting of the Mediterranean Association of Cardiology and Cardiac Surgery, Porotroz, Slovenia, September 22-24, 2005, Abstract No. 11.Google Scholar

  • Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G et al. On behalf of the SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal 2003; 24:987-1003.CrossrefGoogle Scholar

  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.Google Scholar

  • The Expert Committee on Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes. Diabetes Care 2003; 26:3160-3167.Google Scholar

  • Mancia G, Backer GD, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.CrossrefGoogle Scholar

  • Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1115.Google Scholar

  • Laucevicius A. Assessment of early atherosclerosis by noninvasive testing of endothelial dysfunction. Seminars in Cardiology 2002; 8(1):25-28.Google Scholar

  • Laucevicius A, Ryliskyte L, Petrulioniene Z, Kovaite M, Misonis N. First experience with salbutamol - induced changes in the photoplethysmographic digital volume pulse. Seminars in Cardiology 2002; 8(1): 87-93.Google Scholar

  • Ryliskyte L, Laucevicius A, Petrulioniene Z, Kovaite M, Misonis N. Prediction of cardiovascular risk by noninvasive assessment of endothelial vasomotor function. Seminars in Cardiology 2003; 9(1):16-23.Google Scholar

  • Ryliskyte L. Non-invasive assessment of endothelial vasomotor function: methodical aspects and possibilities for clinical application. Vilnius University, 2003.Google Scholar

  • Kovaite M, Petrulioniene Z, Ryliskyte L, Badariene J, Dzenkeviciute V, Cypiene A et al. Systemic assessment of arterial wall structure and function in metabolic syndrome. Proc West Pharmacol Soc 2007; 50:123-130.Google Scholar

  • Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness in clinical practice. QJM 2002; 95:67-74.PubMedCrossrefGoogle Scholar

  • O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15:426-444.CrossrefGoogle Scholar

  • Kovaite M, Petrulioniene Z, Ryliskyte L, Badariene J, Cypiene A, Dzenkeviciute V et al. Relationship of arterial wall parameters to cardiovascular risk factors and cardiovascular risk assessed by SCORE system. Medicina 2007; 43:529-541.Google Scholar

About the article


Published Online: 2012-07-20

Published in Print: 2012-01-01


Citation Information: Seminars in Cardiovascular Medicine, ISSN (Online) 1822-7767, DOI: https://doi.org/10.2478/v10287-012-0003-3.

Export Citation

This content is open access.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Svetlana Solovjova, Ligita Ryliškytė, Jelena Čelutkienė, Jolita Badarienė, Rokas Navickas, Roma Puronaitė, Grytė Bieliauskaitė, Eglė Skiauterytė, Giedrė Lisaitė, and Aleksandras Laucevičius
Blood Pressure, 2016, Volume 25, Number 1, Page 11
[2]
Egidija Rinkūnienė, Aleksandras Laucevičius, Žaneta Petrulionienė, Vilma Dženkevičiūtė, Sandra Kutkienė, Agnė Skujaitė, and Vytautas Kasiulevičius
Clinical Lipidology, 2015, Volume 10, Number 3, Page 219
[3]
Aleksandras Laucevičius, Ligita Ryliškytė, Jūratė Balsytė, Jolita Badarienė, Roma Puronaitė, Rokas Navickas, and Svetlana Solovjova
Medicina, 2015, Volume 51, Number 3, Page 152
[4]
Laurynas Rimševičius, Gintarė Kaklauskaitė, Tomas Rekašius, Jolita Badarienė, Aleksandras Laucevičius, and Marius Miglinas
Medicinos teorija ir praktika, 2014, Volume 20, Number 3, Page 231
[5]
Aleksandras Laucevičius, Egidija Rinkūnienė, Žaneta Petrulionienė, Roma Puronaitė, Vytautas Kasiulevičius, Dalius Jatužis, Ligita Ryliškytė, Jolita Badarienė, Alma Čypienė, Rokas Navickas, Romualdas Kizlaitis, Olivija Gustienė, and Rimvydas Šlapikas
Blood Pressure, 2014, Volume 23, Number 5, Page 281

Comments (0)

Please log in or register to comment.
Log in